Based on the above findings, perhaps we have found a way to effectively reduce neutrophil production and aggregation during the treatment of ARDS due to intrapulmonary factors, and attenuate neutrophil accumulation in the alveoli through inhibition of the CSF3 pathway, in order to effectively improve the prognosis of the disease. Here, CSF3 is linked to acute respiratory distress syndrome.